The purpose of this study is to see if treating household contacts of MDR-TB patients (who are at high risk of developing TB) with delamanid will reduce their risk of developing TB compared to treatment with isoniazid. And if it is safe to treat household contacts of MDR-TB patients with delamanid.
Thank you for your interest, but this study is recruiting by invitation only.
International (Vietnam)
Vivian Go
Health Behavior
Clinical or Medical
Interventional
HIV/AIDS
21-2552
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
